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Background: The purpose of this study was to examine the effect of caregiver status on time trade-off (TTO) and
standard gamble (SG) health state utility scores. Respondents were categorized as caregivers if they reported that
either children or adults depended on them for care.
Methods: This study was a secondary analysis of data from three studies in which general population samples
rated health state descriptions. Study 1: UK; four osteoarthritis health states. Study 2: UK; three adult ADHD health
states. Study 3: US; 16 schizophrenia health states. All three studies included time trade-off assessment. Study 1 also
included standard gamble. Descriptive statistics were calculated to examine willingness to trade in TTO or gamble
in SG. Utilities for caregivers and non-caregivers were compared using t-tests and ANCOVA models.
Results: There were 364 respondents including 106 caregivers (n = 30, 47, and 29 in Studies 1, 2, and 3) and
258 non-caregivers. Most caregivers were parents of dependent children (78.3%). Compared to non-caregivers,
caregivers had more responses at the ceiling (i.e., utility = 0.95), indicating less willingness to trade time or gamble.
All utilities were higher for caregivers than non-caregivers (mean utility difference between groups: 0.07 to 0.16 in
Study 1 TTO; 0.03 to 0.17 in Study 1 SG; 0.06 to 0.10 in Study 2 TTO; 0.11 to 0.22 in Study 3 TTO). These differences
were statistically significant for at least two health states in each study (p < 0.05). Results of sensitivity analyses
with two caregiver subgroups (parents of dependent children and parents of any child regardless of whether
the child was still dependent) followed the same pattern as results of the primary analysis. The parent subgroups
were generally less willing to trade time or gamble (i.e., resulting in higher utility scores) than comparison groups
of non-parents.
Conclusions: Results indicate that caregiver status, including being a parent, influences responses in time trade-off
health state valuation. Caregivers (i.e., predominantly parents) were less willing than non-caregivers to trade time,
resulting in higher utility scores. This pattern was consistent across multiple health states in three studies. Standard
gamble results followed similar patterns, but with less consistent differences between groups. It may be useful to
consider parenting/caregiving status when collecting, interpreting, or using utility data because this demographic
variable could influence results.
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A cost-utility model is a type of cost-effectiveness analysis
that incorporates the preferences of individuals for various
health states, and these preferences are quantified in terms
of utilities [1-3]. Healthcare policy and reimbursement de-
cisions are often directly informed by results of cost-utility
models, and the results of these models depend on the
utility scores. Therefore, it is important to understand fac-
tors that may influence respondents’ decisions in tasks de-
signed to elicit utilities.
There is a substantial body of research on respondent
characteristics that may influence health state preferences
and utility scores. Characteristics that have been found in
at least one study to influence utilities include experience
of the health state being rated [4,5], education level [6,7],
religious beliefs [8-10], age [7,11,12], gender [11], marital
status [11], race [13], and culture [14].
One participant characteristic that has received rela-
tively little attention is whether the respondent is the
caregiver of other individuals such as young children.
One previous study examined the extent to which being
a mother of a young child influenced responses to time
trade-off (TTO) utility assessment [15]. A group of 30
mothers was compared to a large general population
sample, and results indicated that the mothers were not
willing to trade as much time as the general population
sample. Thus, the small sample of mothers had signifi-
cantly higher mean utilities for four generic EQ-5D health
states than the general population. The authors inter-
preted this difference as suggesting that parenting could
affect one’s extrinsic goals, which could influence prefer-
ences during health state valuation.
The purpose of the current study was to analyze data
from three utility studies to examine further the influence
of caregiver status, including being a parent, on utilities.
Because these three utility studies were conducted with dif-
ferent health states, the current analysis can provide insight
into whether the impact of caregiver status is consistent
across multiple samples and health states representing a
range of health conditions. It was expected that caregivers,
compared to non-caregivers, would be more resistant to
trading time in TTO utility assessment and more resistant
to gambling in standard gamble utility assessment. These
tendencies were expected to result in higher utilities for the
same health states for caregivers than for non-caregivers.
Methods
Overview of study design
The current study is a secondary analysis of data from three
studies in which general population respondents completed
utility interviews to rate a series of health state descriptions.
In Study 1, participants in London rated four osteoarthri-
tis health states in time trade-off and standard gamble (SG)
tasks. These health states varied by severity of osteoarthritissymptoms. In Study 2, participants in London and Edin-
burgh rated three adult attention-deficit/hyperactivity dis-
order (ADHD) health states in TTO interviews. These
health states described treatment response, treatment
non-response, and untreated adult ADHD. In Study 3,
participants in San Francisco rated 16 health states in
TTO interviews. These health states described schizo-
phrenia and antipsychotic treatment with a range of ad-
verse events. All TTO utility assessment procedures were
consistent across the three studies, including the use of a
10-year time horizon. Table 1 provides an overview of the
three studies used in this secondary analysis.
For the current analyses, participants were categorized
as caregivers or non-caregivers. Respondents were asked
“Do you have any children?” If they responded “yes,”
they were asked “How many of these children still de-
pend on you to care for them?” Finally, they were asked
“Are there any other people besides children who de-
pend on you to care for them (for example, elderly or
disabled relatives)?” Participants were considered to be
caregivers if they reported that at least one child or one
adult depended on them for care. Otherwise, they were
classified as non-caregivers.
Participants
In all three studies, participants were required to be (1) at
least 18 years old; (2) able to understand the assessment
procedures; and (3) able and willing to give written in-
formed consent. Participants were not eligible if they had
cognitive impairment, hearing difficulty, visual impair-
ment, severe psychopathology, or insufficient knowledge
of English that could interfere with the ability to complete
study measures. Inclusion criteria did not specify any par-
ticular clinical characteristics, which is consistent with
recommendations from agencies like the UK’s National
Institute for Health and Care Excellence (NICE), most of
which prefer that utilities represent general population
preferences [16-18]. Participants were recruited through
newspaper and online classified advertisements.
Study 1
A total of 197 potential participants responded to adver-
tisements, and 109 of these were reached for screening. Of
the 109 screened participants, two were ineligible, 101
were scheduled for interviews, and 81 attended interviews
in London, UK. Of the 81 participants, one was unable to
complete the utility interview procedures. Therefore, the
Study 1 analysis was conducted with the 80 participants
who completed the interview (i.e., 40.6% of individuals
who initially responded to the advertisements).
Study 2
A total of 396 potential participants responded to adver-
tisements, and 203 of these were reached for screening.
Table 1 Data sources for the current secondary analysis
Study characteristics Study 1 Study 2 Study 3
Number of health states 4 3 16
Description of health states Osteoarthritis: three severity levels,
plus one adverse event
Adult ADHD: responder,
non-responder, untreated
Schizophrenia with a range of
treatment-related adverse events
Utility assessment method TTO, SG TTO TTO
Geographic location London (UK) London and Edinburgh (UK) San Francisco (US)
Dates of data collection November 2011 October 2012 April-May 2012
Sample size
Total 80 158 126
Caregivers 30 47 29
Non-caregivers 50 111 97
TTO = Time trade-off; SG = Standard gamble; UK = United Kingdom; US = United States; ADHD = Attention deficit/hyperactivity disorder.
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were scheduled (88 in Edinburgh and 86 in London) for
interviews, and 160 participants attended interviews (81
in Edinburgh and 79 in London). Two of the 160 partici-
pants were unable to complete the utility interview.
Thus, a total of 158 completed utility interviews were
used in the analyses (i.e., 39.9% of individuals who ini-
tially responded to the advertisements), including 80 in
Edinburgh and 78 in London.
Study 3
A total of 376 participants responded to the advertise-
ments, and 202 of these were reached for screening. Of
the 202 screened participants, 192 were eligible, 136 were
scheduled for interviews, and 128 participants attended
interviews in San Francisco, US. Two of the 128 partici-
pants were unable to complete the utility interview.
Therefore, the Study 3 analysis was based on the 126 par-
ticipants who completed the interview (i.e., 33.5% of indi-
viduals who initially responded to the advertisements).
Health states
Study 1
Four osteoarthritis health states associated with elective
total hip arthroplasty were presented during the utility
interview in Study 1. The first three health states de-
scribed patients with mild (health state A), moderate (B),
or severe (C) osteoarthritis of the hip. These health
states were based on health states presented in two pre-
vious studies [19,20], with minor edits made so that they
would be appropriate for administration in the UK. A
fourth health state (D) was identical to health state B,
except for the addition of an adverse event: “Because of
your medication, you occasionally have an upset stom-
ach that causes discomfort and loss of appetite.”
Study 2
Three adult ADHD health states were presented during
the utility interview in Study 2: (A) Adult ADHD,receiving medication treatment, responder; (B): Adult
ADHD, receiving medication treatment, non-responder;
and (C): Adult ADHD, untreated. These health states were
drafted based on literature review, four clinician inter-
views (all four with MD degrees; two of whom also had
PhD degrees), and pooled data from six clinical trials. The
literature review was conducted first to ensure that the
health states would be grounded in clinical evidence. This
literature was then used to draft structured interview
guides for the clinician interviews. The data from the clin-
ical trials was examined to ensure that health states accur-
ately described differences between treatment responders
and non-responders.
Study 3
In order to estimate the disutility associated with adverse
events commonly associated with antipsychotic treat-
ment for schizophrenia, participants in Study 3 first
rated health state A (i.e., the “basic health state”), which
described stable schizophrenia without an adverse event.
Then, 15 additional health states were rated, each in-
cluding the basic health state plus one treatment-related
adverse event. These health states were drafted based on
literature review and a series of interviews with three cli-
nicians (two with MD degrees and one with a PharmD)
who had experience treating patients with schizophrenia.
Utility interview procedures and scoring
Interviews were conducted in London for Study 1, in
London and Edinburgh for Study 2, and in San Francisco
for Study 3 (see Table 1 for dates of data collection). All
procedures were approved by an independent Institutional
Review Board, and participants provided written informed
consent prior to completing any part of each study.
First, participants in each study rated the health states
in a visual analogue scale (VAS) or ranking exercise that
was intended to introduce participants to each of the
health state descriptions. In the VAS and ranking exer-
cises, health states were presented to respondents in
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using TTO methods for all three studies, in addition to
SG methods for Study 1. In Study 1, half of the partici-
pants were randomly assigned to complete the TTO task
first, while the other half completed the SG task first. In
TTO and SG procedures, health states were presented
in the order in which they were previously ranked by
participants, proceeding from best to worst.
TTO and SG interviews followed generally accepted
procedures, which have previously been described in de-
tail [1,21]. In the TTO task, participants were offered a
choice between spending 10 years in the health state be-
ing rated versus spending varying shorter amounts of
time in full health, followed by death. Time was varied
in 1-year increments. The utility score was calculated
based on the choice in which the respondent was indif-
ferent between y years in the health state being evaluated
(i.e., 10 years) and x years in full health (followed by
dead). The resulting utility estimate (u) is calculated as
u = x/y.
In the SG task in Study 1, participants were offered a
choice between two alternatives, one that was certain
and one that was uncertain. Choice A was to remain in
the health state being rated for 10 years. Choice B was
the uncertain choice with two possible outcomes; either
to (1) remain in full health for the 10-year period with a
probability of p or (2) death with a probability of 1 – p.
Probability p was varied in 10% increments until the par-
ticipant was indifferent between choices A and B, and
the resulting utility score was calculated based on p at
this point of indifference.
In Study 1, precise utility scores were not obtained for
health states considered worse than being dead for each
respondent (i.e., negative utility scores). Therefore, “worse
than dead” ratings in Study 1 are used in categorical ana-
lyses (e.g., counted among the frequencies of utilities less
than 0.95), but not in continuous analyses which require
precise utility scores.
In Studies 2 and 3, if participants indicated that a health
state was worse than being dead, the interviewer altered
the task so that respondents were offered a choice be-
tween immediate death (alternative 1) and a 10-year life
span (alternative 2) beginning with varying amounts of
time in the health state being rated, followed by full health
for the remainder of the 10-year timeframe. For these
health states that received negative utility scores, the
current study used a bounded scoring approach, which is
commonly used [21]. This scoring approach limits the
score range of negative scores between 0 and −1. To com-
pute these utilities, analyses of Studies 2 and 3 used the
Dolan [22] method as described by Rowen & Brazier [1].
This method uses the formula u = −x/t, where x is the
number of years in full health, and t is the total life
span of alternative 2 in the TTO choice. In the currentstudy, t was 10 years, which is equal to the number of
years in the health state being rated plus subsequent
years in full health.
Statistical analysis procedures
Statistical analyses were completed using SAS version 8.12
(SAS Institute, Cary, NC). For each of the three studies,
demographic variables, willingness to trade (in TTO), will-
ingness to gamble (in SG for Study 1 only), and mean util-
ities are reported for two subgroups (caregivers and non-
caregivers, categorized as described in the section above
titled “Overview of Study Design”). Caregivers and non-
caregivers were compared in terms of willingness to trade
in TTO and willingness to gamble in SG with chi-square
analyses comparing rates of utility scores below 0.95. A
score of 0.95 indicates that a respondent was unwilling
to trade or gamble, while a score below 0.95 indicates
that a respondent was willing to trade or gamble. Utilities
for caregivers and non-caregivers were compared using
t-tests. After completing the initial t-tests, the utility com-
parisons were re-run as analyses of covariance (ANCOVA
models) controlling for demographic variables that were
significantly different between the two subgroups (i.e.,
gender and marital status in Studies 1 and 2; ethnicity and
marital status in Study 3).
Sensitivity analyses were conducted in order to ascertain
whether results for parents were similar to results for
caregivers in general. All analyses described above were
re-run twice, with two different ways of categorizing the
sample. First, analyses were conducted to examine only
the caregivers who were parents of dependent children,
rather than the larger group of caregivers of adults and/or
children that was the focus of the main analysis described
above. These parents of dependent children were compared
to all other respondents. Second, analyses were re-run fo-
cusing on all parents in the sample, regardless of whether
their children still depended on them for care. These par-
ents were compared to all non-parents in the sample.
Results
Sample description
In total, the current analysis was conducted with data
from 364 general population respondents across the
three studies, including 106 (29.1%) categorized as care-
givers and 258 (70.9%) categorized as non-caregivers. Of
the 30 participants with dependents in Study 1, 25 re-
ported that they were parents of dependent children,
while the other five reported being caregivers of adults.
In Study 1, there were no statistically significant differ-
ences between caregivers (n = 30) and non-caregivers
(n = 50) in age, ethnicity, employment status, or educa-
tion level (Table 2). However, there were significant
between-group differences in gender and marital status.
Compared to non-caregivers, the caregiver group was
Table 2 Demographic characteristics














Age (mean, SD) 48.3 (11.5) 46.7 (15.9) 0.64 44.9 (11.1) 47.9 (15.6) 0.23 48.9 (11.2) 49.7 (16.9) 0.82
Gender (n,%)
Male 20 (66.7%) 21 (42.0%) 0.03 15 (31.9%) 65 (58.6%) <0.01 12 (41.4%) 48 (49.5%) 0.44
Female 10 (33.3%) 29 (58.0%) 32 (68.1%) 46 (41.4%) 17 (58.6%) 49 (50.5%)
Ethnicity (n,%)*
White 15 (50.0%) 35 (70.0%) 0.07 41 (87.2%) 91 (82.0%) 0.42 10 (34.5%) 58 (59.8%) 0.02
Other 15 (50.0%) 15 (30.0%) 6 (12.8%) 20 (18.0%) 19 (65.5%) 39 (40.2%)
Marital status (n,%)
Single 8 (26.7%) 29 (58.0%) 0.02 10 (21.3%) 54 (48.6%) <0.01 9 (31.0%) 59 (60.8%) 0.02
Married/Living with
partner
11 (36.7%) 12 (24.0%) 26 (55.3%) 35 (31.5%) 8 (27.6%) 13 (13.4%)
Divorced/Separated/
Widowed
11 (36.7%) 9 (18.0%) 11 (23.4%) 22 (19.8%) 12 (41.4%) 25 (25.8%)
Employment status
(n,%)†
Full-time work 8 (26.7%) 12 (24.0%) 0.12 17 (36.2%) 35 (31.5%) 0.11 7 (24.1%) 16 (16.5%) 0.15
Part-time work 10 (33.3%) 18 (36.0%) 16 (34.0%) 24 (21.6%) 12 (41.4%) 24 (24.7%)
Unemployed 1 (3.3%) 10 (20.0%) 2 (4.3%) 17 (15.3%) 3 (10.3%) 17 (17.5%)
Other 11 (36.7%) 10 (20.0%) 12 (25.5%) 35 (31.5%) 7 (24.1%) 40 (41.2%)
Education Level
(n,%)
No university degree 16 (53.3%) 25 (50.0%) 0.77 34 (72.3%) 64 (57.7%) 0.08 14 (48.3%) 44 (45.4%) 0.78
University or
postgraduate degree
14 (46.7%) 25 (50.0%) 13 (27.7%) 47 (42.3%) 15 (51.7%) 53 (54.6%)
*For Study 1, other ethnicity includes 13 Black, 8 Asian, and 9 other races. For Study 2, other ethnicity includes 7 Black, 8 Asian, 1 Chinese and 10 mixed races.
For Study 3, other ethnicity includes 24 Black, 10 Hispanic/Latino, 10 Asian, 5 Hawaiian/Pacific Islander and 9 other races.
†For Study 1, other employment includes 3 homemakers, 2 students, 15 retired and 1 disabled. For Study 2, other employment includes 8 homemakers, 9
students, 27 retired, and 3 disabled. For Study 3, other employment includes 3 homemakers, 8 students, 15 retired, 19 disabled and 1 other.
‡P-values are for the comparison between caregivers and non-caregivers. Continuous variables were compared with t-tests, and categorical variables were
compared with chi-square analysis.
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single (p = 0.02).
In Study 2, 47 of the 158 participants were categorized
as caregivers. Of the 47, 39 reported that they were par-
ents of dependent children, four were caregivers of adults,
and another four reported that they were both parents of
dependent children and caregivers of adults (i.e., a total
of 43 respondents were parents of dependent children).
Similar to Study 1, there were no statistically significant
between-group differences in age, ethnicity, employment
status, or education level (Table 2). However, there were
significant differences in gender and marital status. Com-
pared to the group without dependents, the group with
dependents was more likely to be female (p < 0.01) and
married or living with a partner (p < 0.01).
In Study 3, 29 of 126 participants were categorized as
caregivers, including 19 who reported that they were par-
ents of dependent children. Six reported being caregivers ofadults, and four reported being both parents of dependent
children and caregivers of adults (i.e., a total of 23 respon-
dents were parents of dependent children). There were no
statistically significant between-group differences in age,
gender, employment status, or education level (Table 2).
There were significant differences between caregivers and
non-caregivers in ethnicity and marital status. Compared to
non-caregivers, the caregiver group was more likely to be
non-white (p = 0.02) and separated (p = 0.02).
Gender frequencies within each caregiver status group
followed a different pattern in Study 1 than in Studies 2
and 3 (Table 2). Caregivers in Studies 2 and 3 were more
likely to be female, whereas caregivers in Study 1 were
more likely to be male. Because the gender frequencies
in Study 1 were contrary to results from Studies 2 and 3,
which had larger samples, this finding was confirmed by
re-checking and re-tabulating gender and caregiver sta-
tus from the original demographic questionnaires. This
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tics are reported correctly.
Willingness to trade time or gamble
If the respondent is unwilling to trade any time in the
TTO task or unwilling to gamble in the SG task, the result-
ing utility will be at the ceiling, which was 0.95 in the
current analysis. Compared to non-caregivers, caregivers
had fewer health state utilities less than 0.95 and more re-
sponses at the ceiling, indicating less willingness to trade
time or gamble. This pattern was consistent across all three
studies and across almost all health states. For all health
states in Studies 1 and 2 (Tables 3 and 4), a smaller per-
centage of caregivers had utilities less than 0.95 compared
with non-caregivers. In Study 3 (Table 4), a smaller per-
centage of caregivers had scores less than 0.95 for 14 of 16
health states (the exceptions were health states F and H).
For example, in Study 1, while only 23.3% of caregivers
were willing to trade time to avoid health state A, 46.0%
of non-caregivers were willing to trade time. Chi-square
analyses found that these differences between groups were
statistically significant for two health states in Study 1 and
two health states in Study 3. In sum, these findings indi-
cate a greater ceiling effect for caregivers than for non-
caregivers across all three samples.
Utilities
For every health state in all three samples, caregivers
had higher utilities than non-caregivers. The difference
in utility scores between caregivers and non-caregiversTable 3 Frequency and percentage of respondents with
values less than 0.951 (Study 1)
Health states Caregivers Non-caregivers p-value2
(N = 30) (N = 50)
Time trade-off
HS A: Mild Osteoarthritis 7 (23.3%) 23 (46.0%) 0.04
HS B: Moderate Osteoarthritis 12 (40.0%) 31 (62.0%) 0.06
HS C: Severe Osteoarthritis 21 (70.0%) 46 (92.0%) < 0.01
HS D: Moderate Osteoarthritis
+ AE
14 (46.7%) 34 (68.0%) 0.06
Standard gamble
HS A: Mild Osteoarthritis 5 (17.2%) 9 (18.4%) 0.90
HS B: Moderate Osteoarthritis 9 (31.0%) 16 (32.7%) 0.88
HS C: Severe Osteoarthritis 20 (69.0%) 40 (81.6%) 0.20
HS D: Moderate Osteoarthritis
+ AE
11 (37.9%) 20 (40.8%) 0.80
1Values less than 0.95 indicate willingness to trade in time trade-off choices
and willingness to gamble in standard gamble choices. For the descriptive
analyses in this table, ratings worse than dead were categorized as less
than 0.95.
2Based on chi-square analyses comparing caregivers and non-caregivers.
HS = Health state.
AE = Adverse event.ranged from 0.07 to 0.16 for TTO utilities and 0.03 to
0.17 for SG utilities in Study 1 (Table 5). The between-
group difference in TTO utilities ranged from 0.06 to 0.10
in Study 2, and from 0.11 to 0.22 in Study 3 (Table 6). In
seven of the eight pairwise comparisons for Study 1, as
well as all comparisons for Studies 2 and 3, the mean util-
ity difference between caregivers and non-caregivers was
sufficiently large to be considered clinically important
(i.e., utility difference ≥ 0.05 [23]). The differences between
caregivers and non-caregivers were statistically significant
(p < 0.05) for some health states, including health states A
and C in the TTO task in Study 1 and health state C in
the SG task in Study 1 (Table 5). In Study 2, the between-
group difference in TTO utilities was statistically signifi-
cant for all three health states (Table 6). In Study 3, the
between-group difference was statistically significant for
health states J and P (Table 6).
Analyses were re-run as ANCOVA models, controlling
for demographic variables that were statistically significant
between groups (i.e., gender and marital status in Studies 1
and 2; ethnicity and marital status in Study 3). All differ-
ences between caregivers and non-caregivers that were sta-
tistically significant in the t-tests (Tables 5 and 6) were also
statistically significant in these ANCOVA models. This
suggests that between-group differences were due to care-
giver status rather than other demographic differences. The
ANCOVA models found one additional statistically signifi-
cant difference between caregivers and non-caregivers
(health state B in Study 3).
Sensitivity analysis: parents
All analyses were re-run focusing on the 83 parents of
dependent children (n = 25 in Study 1; n = 39 in Study 2;
n = 19 in Study 3). These analyses followed the same pat-
terns as those for the larger caregiver group. Compared
with respondents who were not parents of dependent
children, these parents were less likely to trade any time
in TTO tasks for every health state rated across the three
studies. This difference was statistically significant for five
of the 23 health states (p < 0.05). In addition, these parents
had lower TTO utility scores for every health state, with
utility differences ranging from 0.06 to 0.14 in Study 1,
0.07 to 0.11 in Study 2, and 0.07 to 0.32 in Study 3. These
utilities or differences were statistically significant for five
of the 23 health states (p < 0.05). The SG results in Study 1
followed similar patterns, with lower utility scores and less
willingness to gamble among these parents of dependent
children than among the comparison group.
These analyses were also re-run focusing on the 173
participants who reported being parents, regardless of
whether their children still depended on them for care
(n = 33 in Study 1; n = 89 in Study 2; n = 51 in Study 3).
These analyses followed the same patterns as those for
the caregiver group and the group consisting of parents
Table 4 Frequency and percentage of respondents with TTO utility values less than 0.951 (Studies 2 and 3)
Health states Caregivers Non-caregivers p-value2
Study 2 (Caregivers, n = 47, Non-caregivers, n = 111)
A. Adult ADHD, receiving treatment, responder 24 (51.1%) 65 (58.6%) 0.39
B. Adult ADHD, receiving treatment, non-responder 33 (70.2%) 86 (77.5%) 0.33
C. Adult ADHD, untreated 34 (72.3%) 88 (79.3%) 0.34
Study 3 (Caregivers, n = 29, Non-caregivers, n = 97)
A. Basic HS (stable schizophrenia, no adverse events) 20 (69.0%) 73 (75.3%) 0.50
B. Basic HS + metabolic syndrome 22 (75.9%) 86 (88.7%) 0.08
C. Basic HS + weight gain 23 (79.3%) 78 (80.4%) 0.90
D. Basic HS + diabetes 21 (72.4%) 83 (85.6%) 0.10
E. Basic HS + hyperlipidemia 21 (72.4%) 83 (85.6%) 0.10
F. Basic HS + male sexual dysfunction 10 (83.3%) 39 (81.3%) 0.87
G. Basic HS + female sexual dysfunction 13 (76.5%) 41 (83.7%) 0.51
H. Basic HS +male increased prolactin levels 10 (83.3%) 40 (83.3%) 1.00
I. Basic HS + female increased prolactin levels 12 (70.6%) 43 (87.8%) 0.10
J. Basic HS + akathisia 22 (75.9%) 84 (86.6%) 0.17
K. Basic HS + tardive dyskinesia 24 (82.8%) 90 (92.8%) 0.11
L. Basic HS + other extrapyramidal symptoms 23 (79.3%) 91 (93.8%) 0.02
M. Basic HS + insomnia 20 (69.0%) 83 (85.6%) 0.04
N. Basic HS + somnolence 21 (72.4%) 83 (85.6%) 0.10
O. Basic HS + nausea 20 (69.0%) 80 (82.5%) 0.11
P. Basic HS + vomiting 21 (72.4%) 81 (83.5%) 0.18
1Values less than 0.95 indicate willingness to trade in time trade-off choices.
2Based on chi-square analyses comparing caregivers and non-caregivers.
HS = Health state.
ADHD = Attention deficit/hyperactivity disorder.
TTO = Time trade-off.
Table 5 Health state utilities* (Study 1)
Health states Caregivers (N = 30) Non-caregivers (N = 50) Difference t statistic p-value
n† Mean (SD) Min-Max n† Mean (SD) Min-Max
Time trade-off
HS A: Mild Osteoarthritis 30 0.92 (0.06) 0.75-0.95 50 0.85 (0.13) 0.45-0.95 0.07 (0.11) 3.2 <0.01
HS B: Moderate Osteoarthritis 30 0.84 (0.19) 0.05-0.95 49 0.76 (0.23) 0.00-0.95 0.08 (0.22) 1.6 0.11
HS C: Severe Osteoarthritis 24 0.69 (0.28) 0.15-0.95 42 0.53 (0.29) 0.05-0.95 0.16 (0.28) 2.3 0.03
HS D: Moderate Osteoarthritis + AE 30 0.82 (0.21) 0.05-0.95 48 0.72 (0.26) 0.00-0.95 0.10 (0.25) 1.8 0.07
Standard gamble
HS A: Mild Osteoarthritis 29 0.93 (0.05) 0.75-0.95 49 0.90 (0.12) 0.45-0.95 0.03 (0.10) 1.4 0.16
HS B: Moderate Osteoarthritis 29 0.89 (0.10) 0.60-0.95 48 0.84 (0.20) 0.25-0.95 0.05 (0.17) 1.5 0.13
HS C: Severe Osteoarthritis 24 0.79 (0.19) 0.35-0.95 40 0.61 (0.33) 0.05-0.95 0.17 (0.28) 2.7 <0.01
HS D: Moderate Osteoarthritis + AE 29 0.88 (0.11) 0.60-0.95 47 0.81 (0.23) 0.15-0.95 0.07 (0.20) 1.7 0.09
*Based on t-tests comparing means of the two groups. Utility ratings worse than dead are not included in this table. In Study 1, a precise utility value was not
obtained when a respondent considered a health state to be worse than dead (i.e., utility < 0). Therefore, participants who considered a health state to be worse
than dead have missing data for that health state in this table.
†In Study 1, sample size varied for each individual health state because a specific utility value was not derived if a respondent believed that health state was
worse than being dead.
HS = Health state.
AE = Adverse event.
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Table 6 Time trade-off utilities* (Studies 2 and 3)
Health states Caregivers (N = 47) Non-caregivers (N = 111) Difference t statistic p-value
n Mean (SD) Min-Max n Mean (SD) Min-Max
Study 2
A. Adult ADHD, receiving treatment, responder 47 0.87 (0.11) 0.45-0.95 111 0.80 (0.19) −0.05-0.95 0.06 (0.17) 2.7 <0.01
B. Adult ADHD, receiving treatment, non-responder 47 0.75 (0.21) 0.05-0.95 111 0.65 (0.30) −0.75-0.95 0.10 (0.28) 2.5 0.02
C. Adult ADHD, untreated 47 0.73 (0.23) 0.05-0.95 111 0.64 (0.30) −0.65-0.95 0.10 (0.28) 2.2 0.03
Study 3
A. Basic HS (stable schizophrenia, no adverse events) 29 0.68 (0.35) −0.55-0.95 97 0.56 (0.45) −0.75-0.95 0.11 (0.43) 1.3 0.21
B. Basic HS + metabolic syndrome 29 0.62 (0.35) −0.55-0.95 97 0.44 (0.49) −0.85-0.95 0.18 (0.46) 1.9 0.06
C. Basic HS + weight gain 29 0.64 (0.36) −0.55-0.95 97 0.51 (0.47) −0.85-0.95 0.12 (0.45) 1.3 0.19
D. Basic HS + diabetes 29 0.58 (0.39) −0.55-0.95 97 0.43 (0.50) −0.95-0.95 0.15 (0.48) 1.5 0.13
E. Basic HS + hyperlipidemia 29 0.61 (0.38) −0.55-0.95 97 0.47 (0.47) −0.85-0.95 0.13 (0.45) 1.4 0.16
F. Basic HS + male sexual dysfunction† 12 0.57 (0.29) 0.05-0.95 48 0.47 (0.45) −0.85-0.95 0.11 (0.43) 0.8 0.44
G. Basic HS + female sexual dysfunction† 17 0.61 (0.43) −0.55-0.95 49 0.45 (0.52) −0.75-0.95 0.16 (0.50) 1.2 0.25
H. Basic HS + male increased prolactin levels† 12 0.62 (0.27) 0.05-0.95 48 0.44 (0.47) −0.85-0.95 0.17 (0.44) 1.7 0.10
I. Basic HS + female increased prolactin levels† 17 0.63 (0.41) −0.55-0.95 49 0.44 (0.50) −0.75-0.95 0.19 (0.48) 1.4 0.17
J. Basic HS + akathisia 29 0.62 (0.35) −0.55-0.95 97 0.43 (0.51) −0.85-0.95 0.19 (0.48) 2.3 0.03
K. Basic HS + tardive dyskinesia 29 0.47 (0.49) −0.85-0.95 97 0.25 (0.60) −0.95-0.95 0.22 (0.58) 1.8 0.07
L. Basic HS + other extrapyramidal symptoms 29 0.41 (0.52) −0.85-0.95 97 0.25 (0.57) −0.95-0.95 0.16 (0.56) 1.4 0.17
M. Basic HS + insomnia 29 0.65 (0.38) −0.55-0.95 97 0.49 (0.47) −0.85-0.95 0.16 (0.45) 1.7 0.09
N. Basic HS + somnolence 29 0.64 (0.36) −0.55-0.95 97 0.48 (0.47) −0.85-0.95 0.16 (0.44) 1.7 0.10
O. Basic HS + nausea 29 0.62 (0.44) −0.65-0.95 97 0.50 (0.48) −0.95-0.95 0.11 (0.47) 1.1 0.26
P. Basic HS + vomiting 29 0.65 (0.36) −0.55-0.95 97 0.45 (0.51) −0.95-0.95 0.20 (0.48) 2.4 0.02
*Based on t-tests comparing means of the two groups.
†In Study 3, sample size was smaller for health states representing sexual dysfunction and increased prolactin because each participant rated only the gender-specific
health state.
HS = Health state.
ADHD = Attention deficit/hyperactivity disorder.
Matza et al. Health and Quality of Life Outcomes 2014, 12:48 Page 8 of 11
http://www.hqlo.com/content/12/1/48of dependent children. Compared with non-parents,
these parents were less likely to trade any time in TTO
tasks for every health state rated across the three studies.
This difference was statistically significant for four of the
23 health states (p < 0.05). In addition, these parents had
lower TTO utility scores than non-parents for every
health state, with utility differences ranging from 0.05 to
0.19 in Study 1, 0.03 to 0.09 in Study 2, and 0.03 to 0.09
in Study 3. These utilities or differences were statistically
significant for seven of the 23 health states (p < 0.05).
The SG results in Study 1 followed similar patterns, with
lower utility scores and less willingness to gamble among
parents than among non-parents.
Discussion
Taken together, results across three independent data
sets for a wide range of health states provide strong sup-
port for the hypothesis that being a caregiver influences
the way one responds in a TTO health state valuation
task. Compared to respondents who were not caregivers,
caregivers tended to be less willing to trade any time inthe TTO tasks. Furthermore, when caregivers did trade,
they tended to trade less time, resulting in consistently
higher utility scores than non-caregivers. The difference
between caregivers and non-caregivers in health state
utility was often quite large, with between-group differ-
ences up to 0.22 on the standard utility scale anchored
to 0 (dead) and 1 (full health). Utility differences of this
magnitude are large enough to have a substantial impact
on the outcome of a cost-utility model. Thus, caregiver
status may be an important demographic variable to
consider when collecting, interpreting, or using utility
data. The current results also serve as a reminder that
health state utilities are shaped not only by the health
states themselves, but also by characteristics of the re-
spondent valuing the health states.
SG data were not available in the data sets for Studies
2 or 3, but in Study 1, caregiver status appeared to have
less influence on SG responses than on TTO responses.
For example, caregiver status had a less pronounced im-
pact on willingness to gamble in SG than on willingness
to trade in TTO (Table 3). In addition, mean differences
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were smaller for SG than TTO for three of the four health
states in Study 1 (Table 5). Perhaps the SG task is less
susceptible than TTO to the respondent’s current life
situation because of the abstract nature of the task. In
the TTO, participants may consider the direct impact of
shorter lifespan on their dependents, whereas the prob-
abilities involved in the SG task may not lead respondents
to think of their own responsibilities as directly. Still, SG
utilities had a smaller utility range for caregivers than
for non-caregivers, the caregivers did have statistically
significantly higher SG utilities for health state C, and
between-group differences for health states B and D may
be considered clinically important (Table 5 [23]). In sum,
while results of the TTO task appear to be more strongly
influenced by caregiver status, SG responses may also be
affected. Future research is needed to clarify the impact of
caregiver status on SG responses.
Current findings add to results reported by van der
Pol & Shiell [15] suggesting that people are less willing
to trade time in the hypothetical TTO task if they know
that others are directly dependent on them. Whereas the
van der Pol & Shiell [15] study focused only on a sample
of 30 parents of young children, the current study in-
cluded both parents of dependent children and individ-
uals who considered themselves to be caregivers of an
adult. This broader group was used because respondents
in previous utility assessment studies (conducted by au-
thors of the current studies) have mentioned the impact
of caring for an elderly or disabled relative. However, the
great majority of caregivers in the current study cared
for children rather than adults (i.e., 83 of 106 caregivers;
78.3%). As a sensitivity analysis, current analyses were
re-run in two other subgroups: including parents of
dependent children and parents of any child regardless
of whether the child is still dependent. Results of these
sensitivity analyses followed the same general pattern as
results of the primary analysis. The parent subgroups
were generally less willing to trade time (i.e., resulting in
higher utility scores) than comparison groups. Future
research, perhaps involving qualitative interviews asking
participants to explain their TTO responses, is needed
to explore the separate influence, if any, of parenting and
other types of caregiving on utility scores. The current
analysis may also be replicated in larger samples with vari-
ous types of caregivers, including larger numbers of care-
givers of adults.
Parenting and other types of caregiving may reduce
willingness to trade due to increased altruism and a
sense of responsibility for another individual’s well-
being. In addition, even if a child is grown, being a par-
ent may reduce willingness to trade because parents may
want to live longer to experience specific milestones in
their child’s life. For example, parents have reported thatthey wanted to live long enough to see their child’s wed-
ding or graduation when responding in previous TTO
studies conducted by the authors of the current study.
Such extrinsic goals, which occur at a specific point in the
future, have been proposed as one factor that could limit
willingness to trade time in TTO or gamble in SG [24].
Current results also have implications for the conceptual
foundations of utility assessments. The standard prefer-
ence elicitation and quality-adjusted life year (QALY)
models ask respondents to evaluate health states based on
the effects on their own welfare. However, results reported
in this paper and elsewhere in the literature suggest that
respondents also consider the effects of their health on
the welfare of others when valuing health states. Several
authors have developed conceptual frameworks that
broaden the utility model to take into account not only
the preferences of respondents for their own health out-
comes, but also their preferences for effects on other
people such as spouses, children, and adult dependents.
These frameworks are often referred to as a family or
household utility function [25-27]. Current findings sug-
gest that future research to develop and implement
these family or household utility approaches could be
useful, although this methodology could be complex,
and the scores may not be entirely comparable to con-
ventional utilities.
Study limitations related to sample selection should be
acknowledged. During screening, efforts were made to
avoid over-representing respondents from any particular
age, ethnic/racial background, gender, or employment
group. However, recruitment was not stratified or de-
signed to be nationally representative in any of the three
studies used for this secondary analysis. Furthermore,
the recruitment strategy, requiring that all study partici-
pants respond to newspaper or online advertisements,
could have introduced selection bias. The extent to
which current results may differ from utilities derived
from a nationally representative sample in the US, UK,
or any other country is not known.
Another potential limitation is that a respondent’s per-
sonal experience with the condition described in health
states could influence utility scores. In Studies 2 and 3,
none of the participants were ever diagnosed with the con-
dition described in the health states (ADHD and schizo-
phrenia, respectively), although it is possible that they
knew people who had received these diagnoses. It is not
known whether participants in Study 1 had ever been diag-
nosed with the condition described in the health states
(osteoarthritis). Personal knowledge of the conditions be-
ing rated could have an impact on utility scores, and it is
not known whether this was a confounding factor in the
current analysis.
It is also possible that aspects of the interview method-
ology could have introduced bias. For example, although
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random order during ranking or VAS introductory tasks,
health states were then presented in the TTO tasks in the
order in which participants ranked them. At multiple
points during the interviews and at the end of the inter-
views, participants were asked to review and compare all
of their utility scores in order to minimize ordering effects
and learning effects that could affect differences among
health states. Furthermore, if there were any ordering or
learning effects, any resulting biases would likely be the
same for caregivers and non-caregivers, and consequently,
this issue is unlikely to have an impact on the issues exam-
ined in the current secondary analysis.
Conclusions
In sum, the current study indicates that parenting and
potentially other types of caregiving appear to influence
TTO utilities. Subsequent research may be conducted to
replicate current findings in independent cohorts of par-
ents with dependent children as well as among care-
givers of adults. In future TTO studies, it may also be
useful to assess parenting and adult caregiving status
along with other demographic variables such as gender,
age, and education. Samples with higher percentages of
parents or caregivers may tend to yield higher utility
scores. Thus, it may be helpful to know these respond-
ent characteristics when interpreting data and compar-
ing utilities across multiple studies.
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